[go: up one dir, main page]

AU2002323443A1 - Compositions and methods for the diagnosis and treatment of herpes simplex virus infection - Google Patents

Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

Info

Publication number
AU2002323443A1
AU2002323443A1 AU2002323443A AU2002323443A AU2002323443A1 AU 2002323443 A1 AU2002323443 A1 AU 2002323443A1 AU 2002323443 A AU2002323443 A AU 2002323443A AU 2002323443 A AU2002323443 A AU 2002323443A AU 2002323443 A1 AU2002323443 A1 AU 2002323443A1
Authority
AU
Australia
Prior art keywords
diagnosis
compositions
treatment
methods
herpes simplex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002323443A
Inventor
Craig H. Day
Nancy A. Hosken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2002323443A1 publication Critical patent/AU2002323443A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/13—B-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/17—Monocytes; Macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002323443A 2001-09-04 2002-08-27 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection Abandoned AU2002323443A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31715901P 2001-09-04 2001-09-04
US60/317,159 2001-09-04
US37342902P 2002-04-17 2002-04-17
US60/373,429 2002-04-17
PCT/US2002/027341 WO2003020108A2 (en) 2001-09-04 2002-08-27 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

Publications (1)

Publication Number Publication Date
AU2002323443A1 true AU2002323443A1 (en) 2003-03-18

Family

ID=26980813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002323443A Abandoned AU2002323443A1 (en) 2001-09-04 2002-08-27 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

Country Status (2)

Country Link
AU (1) AU2002323443A1 (en)
WO (1) WO2003020108A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010249330B2 (en) 2009-05-22 2015-11-05 Genocea Biosciences Inc. Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
AU2011336894B2 (en) 2010-11-24 2016-11-17 Genocea Biosciences, Inc. Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
WO2013006401A2 (en) * 2011-07-01 2013-01-10 Immport Therapeutics, Inc. Methods and compositions of protein antigens for the diagnosis and treatment of herpes simplex viruses type 1 and 2
AU2012340712B2 (en) 2011-11-23 2017-09-14 Genocea Biosciences, Inc. Nucleic acid vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
EP3519427A4 (en) 2016-09-28 2020-03-11 Genocea Biosciences Inc. METHOD AND COMPOSITIONS FOR TREATING HERPES

Also Published As

Publication number Publication date
WO2003020108A2 (en) 2003-03-13
WO2003020108A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
EP1492563A4 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU2002347152A1 (en) Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection
AU7743100A (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AU2002312303A1 (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU2281601A (en) Treatment of viral infections using levovirinTM
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU2002323443A1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2003285908A1 (en) Diagnosis and treatment of herpes simplex virus diseases
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
AU2003299493A1 (en) Compositions and methods for the treatment of hepatitis c virus infection
AU3902600A (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase